Authors:
Gupta, S
Stravitz, RT
Pandak, WM
Muller, M
Vlahcevic, ZR
Hylemon, PB
Citation: S. Gupta et al., Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes, HEPATOLOGY, 32(2), 2000, pp. 341-347
Authors:
Larkin, JM
Woo, B
Balan, V
Marks, DL
Oswald, BJ
LaRusso, NF
McNiven, MA
Citation: Jm. Larkin et al., Rab3D, a small GTP-binding protein implicated in regulated secretion, is associated with the transcytotic pathway in rat hepatocytes, HEPATOLOGY, 32(2), 2000, pp. 348-356
Authors:
Terai, S
Aoki, H
Ashida, K
Thorgeirsson, SS
Citation: S. Terai et al., Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression, HEPATOLOGY, 32(2), 2000, pp. 357-366
Authors:
Banerjee, R
Caruccio, L
Zhang, YJ
McKercher, S
Santella, RM
Citation: R. Banerjee et al., Effects of carcinogen-induced transcription factors on the activation of hepatitis B virus expression in human hepatoblastoma HepG2 cells and its implication on hepatocellular carcinomas, HEPATOLOGY, 32(2), 2000, pp. 367-374
Citation: Sj. Pelletier et al., Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation, HEPATOLOGY, 32(2), 2000, pp. 375-381
Authors:
Takyar, ST
Li, DS
Wang, YH
Trowbridge, R
Gowans, EJ
Citation: St. Takyar et al., Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on PolyA(+)-purified RNA, HEPATOLOGY, 32(2), 2000, pp. 382-387
Authors:
Tanaka, E
Ohue, C
Aoyagi, K
Yamaguchi, K
Yagi, S
Kiyosawa, K
Alter, HJ
Citation: E. Tanaka et al., Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplificationof HCV RNA, HEPATOLOGY, 32(2), 2000, pp. 388-393
Authors:
Lau, GKKK
Tsiang, M
Hou, JL
Yuen, ST
Carman, WF
Zhang, L
Gibbs, CS
Lam, SK
Citation: Gkkk. Lau et al., Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study, HEPATOLOGY, 32(2), 2000, pp. 394-399
Authors:
Gordon, SC
Fang, JWS
Silverman, AL
McHutchison, JG
Albrecht, JK
Citation: Sc. Gordon et al., The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C, HEPATOLOGY, 32(2), 2000, pp. 400-404
Authors:
Kato, N
Yoshida, H
Ono-Nita, SK
Kato, J
Goto, T
Otsuka, M
Lan, KH
Matsushima, K
Shiratori, Y
Omata, M
Citation: N. Kato et al., Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer, HEPATOLOGY, 32(2), 2000, pp. 405-412
Authors:
de Man, RA
Marcellin, P
Habal, F
Desmond, P
Wright, T
Rose, T
Jurewicz, R
Young, C
Citation: Ra. De Man et al., A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B, HEPATOLOGY, 32(2), 2000, pp. 413-417
Citation: Sj. Pelletier et al., Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate, HEPATOLOGY, 32(2), 2000, pp. 418-426
Citation: D. Schuppan et Eg. Hahn, Silymarin: What is in the name ...? An appeal for a change of editorial policy - Reply, HEPATOLOGY, 32(2), 2000, pp. 443-444
Authors:
De Maria, N
Idilman, R
Colantoni, A
Harig, JM
Van Thiel, DH
Citation: N. De Maria et al., Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection, HEPATOLOGY, 32(2), 2000, pp. 444-444
Citation: M. Wiedmann et al., Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection - Reply, HEPATOLOGY, 32(2), 2000, pp. 445-445
Citation: Merli, Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation (vol 30, pg 649, 1999), HEPATOLOGY, 32(2), 2000, pp. 446-446
Citation: Poynard, Is an 'A la carte' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? (vol 31, pg 211, 2000), HEPATOLOGY, 32(2), 2000, pp. 446-446
Authors:
Glaser, S
Benedetti, A
Marucci, L
Alvaro, D
Baiocchi, L
Kanno, N
Caligiuri, A
Phinizy, JL
Chowdury, U
Papa, E
LeSage, G
Alpini, G
Citation: S. Glaser et al., Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca2+-, and protein kinase C alpha-dependent mechanisms, HEPATOLOGY, 32(1), 2000, pp. 17-25